{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:32:30Z","timestamp":1772721150422,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11968-5","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T10:19:37Z","timestamp":1756549177000},"page":"2024-2036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary arterial blowout syndrome as a serious adverse event in patients with advanced lung cancer: a 12-year retrospective study"],"prefix":"10.1007","volume":"36","author":[{"given":"Xu","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruowang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Jie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8605-3116","authenticated-orcid":false,"given":"Sen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"11968_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/jamaoncol.2021.6439","volume":"8","author":"MS Anscher","year":"2022","unstructured":"Anscher MS, Arora S, Weinstock C et al (2022) Association of radiation therapy with risk of adverse events in patients receiving immunotherapy: a pooled analysis of trials in the US food and drug administration database. JAMA Oncol 8:232\u2013240","journal-title":"JAMA Oncol"},{"key":"11968_CR2","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","volume":"378","author":"MA Socinski","year":"2018","unstructured":"Socinski MA, Jotte RM, Cappuzzo F et al (2018) Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. N Engl J Med 378:2288\u20132301","journal-title":"N Engl J Med"},{"key":"11968_CR3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jtho.2021.11.018","volume":"17","author":"S Ren","year":"2022","unstructured":"Ren S, Chen J, Xu X et al (2022) Camrelizumab plus carboplatin and paclitaxel as first-line treatment for advanced squamous NSCLC (CameL-Sq): a phase 3 trial. J Thorac Oncol 17:544\u2013557","journal-title":"J Thorac Oncol"},{"key":"11968_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/CLEP.S442152","volume":"16","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Wen Y, Xiang Z et al (2024) Cancer survival trends in Southeastern China, 2011\u20132021: a population-based study. Clin Epidemiol 16:45\u201356","journal-title":"Clin Epidemiol"},{"key":"11968_CR5","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jtho.2017.12.004","volume":"13","author":"A Artal-Cort\u00e9s","year":"2018","unstructured":"Artal-Cort\u00e9s A, Felices-Lobera P, M\u00e1rquez-Medina D (2018) Massive Hemoptysis after the first administration of pembrolizumab in a strongly positive, centrally located NSCLC. J Thorac Oncol 13:e76\u2013e77","journal-title":"J Thorac Oncol"},{"key":"11968_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.lungcan.2011.11.020","volume":"76","author":"E Dansin","year":"2012","unstructured":"Dansin E, Cinieri S, Garrido P et al (2012) MO19390 (SAiL): bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC. Lung Cancer 76:373\u2013379","journal-title":"Lung Cancer"},{"key":"11968_CR7","first-page":"259","volume":"8","author":"AE Russo","year":"2017","unstructured":"Russo AE, Priolo D, Antonelli G, Libra M, McCubrey JA, Ferra\u00f9 F (2017) Bevacizumab in the treatment of NSCLC: patient selection and perspectives. Lung Cancer 8:259\u2013269","journal-title":"Lung Cancer"},{"key":"11968_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.21037\/atm.2019.04.91","volume":"7","author":"E Gershman","year":"2019","unstructured":"Gershman E, Guthrie R, Swiatek K, Shojaee S (2019) Management of hemoptysis in patients with lung cancer. Ann Transl Med 7:358","journal-title":"Ann Transl Med"},{"key":"11968_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01421-7","volume":"15","author":"R Salvayre","year":"2025","unstructured":"Salvayre R, Hanotin C, Parrot A et al (2025) Severe hemoptysis associated with lung cancer in the ICU: recurrence and outcome. Ann Intensive Care 15:33","journal-title":"Ann Intensive Care"},{"key":"11968_CR10","doi-asserted-by":"publisher","unstructured":"Hanotin C, Salvayre R, Lassalle L et al (2024) Predictive factors for recurrent hemoptysis after bronchial artery embolization in patients with lung cancer. J Vasc Interv Radiol. https:\/\/doi.org\/10.1016\/j.jvir.2024.05.017","DOI":"10.1016\/j.jvir.2024.05.017"},{"key":"11968_CR11","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1200\/JCO.22.02543","volume":"41","author":"DH Johnson","year":"2023","unstructured":"Johnson DH, Fehrenbacher L, Novotny WF et al (2023) Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 41:2305\u20132312","journal-title":"J Clin Oncol"},{"key":"11968_CR12","doi-asserted-by":"crossref","unstructured":"Ren S, Wang X, Han BH et al (2024) First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS \u22651%: results from a multicenter, open-label, phase 2 trial. J Immunother Cancer 12:e007227","DOI":"10.1136\/jitc-2023-007227"},{"key":"11968_CR13","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1200\/JCO.2011.37.2623","volume":"29","author":"JC Soria","year":"2011","unstructured":"Soria JC, M\u00e1rk Z, Zatloukal P et al (2011) Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer. J Clin Oncol 29:4442\u20134451","journal-title":"J Clin Oncol"},{"key":"11968_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jvir.2018.08.022","volume":"30","author":"K Han","year":"2019","unstructured":"Han K, Yoon KW, Kim JH, Kim GM (2019) Bronchial artery embolization for hemoptysis in primary lung cancer: a retrospective review of 84 patients. J Vasc Interv Radiol 30:428\u2013434","journal-title":"J Vasc Interv Radiol"},{"key":"11968_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00270-023-03488-w","volume":"46","author":"T Le Tat","year":"2023","unstructured":"Le Tat T, Carlier R, Zhang N et al (2023) Endovascular management of life-threatening hemoptysis in primary lung cancer: a retrospective study. Cardiovasc Intervent Radiol 46:891\u2013900","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11968_CR16","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/annonc\/mdr463","volume":"23","author":"M Reck","year":"2012","unstructured":"Reck M, Barlesi F, Crin\u00f2 L et al (2012) Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts. Ann Oncol 23:1111\u20131120","journal-title":"Ann Oncol"},{"key":"11968_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/JTO.0b013e318168c7e9","volume":"3","author":"EM Marom","year":"2008","unstructured":"Marom EM, Martinez CH, Truong MT et al (2008) Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol 3:351\u2013357","journal-title":"J Thorac Oncol"},{"key":"11968_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1183\/09031936.00010114","volume":"45","author":"K Razazi","year":"2015","unstructured":"Razazi K, Parrot A, Khalil A et al (2015) Severe haemoptysis in patients with nonsmall cell lung carcinoma. Eur Respir J 45:756\u2013764","journal-title":"Eur Respir J"},{"key":"11968_CR19","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1200\/JCO.2013.48.9641","volume":"33","author":"J Peguero","year":"2015","unstructured":"Peguero J, Khanfar A, Mannem S, Willis M, Markowtiz A (2015) Impending carotid blowout syndrome. J Clin Oncol 33:e97\u2013e98","journal-title":"J Clin Oncol"},{"key":"11968_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103088","volume":"155","author":"D Alterio","year":"2020","unstructured":"Alterio D, Turturici I, Volpe S et al (2020) Carotid blowout syndrome after reirradiation for head and neck malignancies: a comprehensive systematic review for a pragmatic multidisciplinary approach. Crit Rev Oncol Hematol 155:103088","journal-title":"Crit Rev Oncol Hematol"},{"key":"11968_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.lungcan.2012.04.006","volume":"77","author":"M Nakanishi","year":"2012","unstructured":"Nakanishi M, Yoshida Y, Natazuka T (2012) Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapy. Lung Cancer 77:353\u2013358","journal-title":"Lung Cancer"},{"key":"11968_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jvir.2018.01.773","volume":"29","author":"C Marcelin","year":"2018","unstructured":"Marcelin C, Soussan J, Desmots F et al (2018) Outcomes of pulmonary artery embolization and stent graft placement for the treatment of hemoptysis caused by lung tumors. J Vasc Interv Radiol 29:975\u2013980","journal-title":"J Vasc Interv Radiol"},{"key":"11968_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000502156","volume":"99","author":"F Jin","year":"2020","unstructured":"Jin F, Li Q, Bai C et al (2020) Chinese expert recommendation for diagnosis and treatment of massive hemoptysis. Respiration 99:83\u201392","journal-title":"Respiration"},{"key":"11968_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1378\/chest.08-2091","volume":"135","author":"M Chawla","year":"2009","unstructured":"Chawla M, Getzen T, Simoff MJ (2009) Medical pneumonectomy: interventional bronchoscopic and endovascular management of massive hemoptysis due to pulmonary artery pseudoaneurysm, a consequence of endobronchial brachytherapy. Chest 135:1355\u20131358","journal-title":"Chest"},{"key":"11968_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fphar.2020.00005","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang X, Wu S, Chen Y et al (2020) Fatal adverse events associated with programmed cell death ligand 1 inhibitors: a systematic review and meta-analysis. Front Pharmacol 11:5","journal-title":"Front Pharmacol"},{"key":"11968_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/JTO.0000000000000227","volume":"9","author":"S Novello","year":"2014","unstructured":"Novello S, Scagliotti GV, Sydorenko O et al (2014) Motesanib plus carboplatin\/paclitaxel in patients with advanced squamous non-small-cell lung cancer: results from the randomized controlled MONET1 study. J Thorac Oncol 9:1154\u20131161","journal-title":"J Thorac Oncol"},{"key":"11968_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2217\/imt-2018-0136","volume":"11","author":"F Facchinetti","year":"2019","unstructured":"Facchinetti F, Majori M, Sabato M, Gnetti L, Tiseo M (2019) Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: Did tumor shrinkage matter?. Immunotherapy 11:161\u2013166","journal-title":"Immunotherapy"},{"key":"11968_CR28","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1111\/1759-7714.13578","volume":"11","author":"R Wang","year":"2020","unstructured":"Wang R, Li K, Pi J, Meng L, Zhu M (2020) Cavitation and fatal hemoptysis after immunotherapy for advanced lung adenocarcinoma: a case report. Thorac Cancer 11:2727\u20132730","journal-title":"Thorac Cancer"},{"key":"11968_CR29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/JTO.0b013e3182582912","volume":"7","author":"EC Phernambucq","year":"2012","unstructured":"Phernambucq EC, Hartemink KJ, Smit EF et al (2012) Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes. J Thorac Oncol 7:1271\u20131275","journal-title":"J Thorac Oncol"},{"key":"11968_CR30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1200\/JCO.2008.16.2412","volume":"27","author":"AB Sandler","year":"2009","unstructured":"Sandler AB, Schiller JH, Gray R et al (2009) Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab. J Clin Oncol 27:1405\u20131412","journal-title":"J Clin Oncol"},{"key":"11968_CR31","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.chest.2018.08.1035","volume":"155","author":"H Deshwal","year":"2019","unstructured":"Deshwal H, Avasarala SK, Ghosh S, Mehta AC (2019) Forbearance with bronchoscopy: a review of gratuitous indications. Chest 155:834\u2013847","journal-title":"Chest"},{"key":"11968_CR32","doi-asserted-by":"publisher","first-page":"31802","DOI":"10.3402\/ecrj.v3.31802","volume":"3","author":"K Nielsen","year":"2016","unstructured":"Nielsen K, Gottlieb M, Colella S, Saghir Z, Larsen KR, Clementsen PF (2016) Bronchoscopy as a supplement to computed tomography in patients with haemoptysis may be unnecessary. Eur Clin Respir J 3:31802","journal-title":"Eur Clin Respir J"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11968-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11968-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11968-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:20:54Z","timestamp":1772716854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11968-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["11968"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11968-5","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Sen Jiang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All of this study has not been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}